BPG is committed to discovery and dissemination of knowledge
Featured Articles
7/7/2020 3:08:01 PM | Browse: 676 | Download: 1112
 |
Received |
|
2020-03-18 16:52 |
|
Peer-Review Started |
|
2020-03-18 16:56 |
|
First Decision by Editorial Office Director |
|
2020-05-15 23:47 |
|
Return for Revision |
|
2020-05-15 23:47 |
|
Revised |
|
2020-06-18 16:16 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-06-22 10:06 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-06-23 01:21 |
|
Articles in Press |
|
2020-06-23 01:21 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-06-30 12:46 |
|
Publish the Manuscript Online |
|
2020-07-07 14:50 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Matteo Tardelli |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Matteo Tardelli, MSc, PhD, Lecturer, Postdoctoral Fellow, Division of Gastroenterology and Hepatology, Joan and Sanford I Weill Cornell Department of Medicine, Weill Cornell Medical College, 413 E. 69th Street, New York, NY 10013, United States. mat4005@med.cornell.edu |
| Key Words |
Lipid metabolism; Monoacylglycerol lipase; Non-alcoholic steatohepatitis; Non-alcoholic fatty liver disease; Cannabinoid; Nuclear receptors |
| Core Tip |
Monoacylglycerol lipase inhibition/modulation is yet unappreciated however attractive therapeutic concept to limit liver disease as fatty acids may drive hepatocyte injury, fibrogenesis and change immune cells phenotype. |
| Publish Date |
2020-07-07 14:50 |
| Citation |
Tardelli M. Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease. World J Gastroenterol 2020; 26(25): 3577-3585 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i25/3577.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i25.3577 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
